Health Special: Lupus and Plasminogen Deficiency
November 6, 2017
Treatment and Trials for Lupus and Plasminogen Deficiency.
This episode of The Balancing Act focuses on two very different diseases: Lupus and Plasminogen Deficiency (PLGD). Fortunately, research is yielding encouraging treatment options for both diseases.
The Lupus Foundation of America estimates that 1.5 million Americans — and at least five million people worldwide — have a form of lupus. Join us for a discussion of lupus and lupus nephritis, meet two courageous women who are battling the disease, plus we examine the latest clinical trials giving hope to medical professionals and sufferers.
Then, in our recurring Behind the Mystery segment, we examine Plasminogen Deficiency (PLGD) or Hypoplasminogenemia, an ultra-rare disease often misdiagnosed. A systemic and potentially life-threatening disease, PLGD frequently presents with ligneous conjunctivitis, an eye condition where the lids develop membranous growths. We meet a young lady who has been dealing with PLGD almost since birth, along with her mother, who has become a vocal advocate.
Send all kinds of mail from home — no supplies or equipment needed, and no trips to the post office. LetterStream does all the work for you.
Xcellerate 35 is an all-new hair regrowth system for the millions of men and women experiencing hair loss.
Founded in 1858, RBC is a global company that brings diverse expertise and deep knowledge to the sophisticated financial needs of their clients around the world.